drugset / Trial / NCT03270735
A Clinical Study to Evaluate the Efficacy and Safety of Hemocoagulase Injection
Phase 4
Unknown
100 enrolled
Lee's Pharmaceutical Limited
Zhaoke Pharmaceutical (Hefei) Company Limited · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multi-centre, randomised, double blind, placebo controlled clinical study which is designed to evaluate the efficacy and safety of hemocoagulase in the treatment of moderate to severe hemoptysis.
Timeline
- Start
- 2017-06-06
- Primary completion
- 2018-06
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hemocoagulase | Protein / enzyme biologic | — | — |
Indications
No indication recorded.